small steps great leaps

Chronic pain and the associated problems drug-based therapies bring to this condition are one of the biggest healthcare issues facing the world today.
Exsurgo is here to change that.

Exsurgo is developing technology and validating the science to treat chronic pain without the use of, and more effectively than, pharmaceuticals.

By taking existing, clinically accepted EEG technology and miniaturising it, Exsurgo has created a consumer-priced, intelligent mobile device, simple enough to be used at home or in a professional clinical setting.

Shown in studies to be as effective as costly clinical-grade equipment that requires specialist staff to operate, Exsurgo is democratising the treatment of chronic pain for everyone, everywhere.
We call it – mindpower to the people.

Mindpower to the people

Mindpower to the people

A REvOLUTION IN PAIN MANAGEMENT – AXON IS A NON-INvASIvE, EASy-TO-USE EEG NEUROfEEDBACk DEvICE THAT HAS NO SIDE- EffECTS OR TOLERANCE BUILD UP.
When wearing the headset, brain-activity data is tracked and displayed on the user’s own mobile device via our app. Through real-time visual feedback, the user learns to neuro- modulate the pain signals by recognising and modifying their response, causing a significant decrease in pain. At a fraction of the price of traditional EEG technology, Axon empowers everyone, everywhere to manage their own treatment from the comfort of their own home.

The deployment of Exsurgo’s technology has the potential to save the UK healthcare economy in the region of US$7.9B per year.

EXTRACT FROM TREATING CHRONIC SEVERE PAIN: THE ROLE OF AXON IN REDUCING GLOBAL COSTS.

Dr Nick Birch FRCS (Orth), Consultant Spinal Specialist

CLINICAL TRIALS

EEG is an established, medically proven process used to evaluate the electrical activity in the brain.
Early clinical studies in the treatment of chronic pain have shown that in-home use of EEG combined with Neurofeedback can be more effective than the current best practice pharmaceuticals.

Exsurgo technology makes EEG Neurofeedback affordable and accessible for the first time, delivering mindpower to the people.

CLINICAL STUDIES By EXSURGO ARE ONGOING AND PROGRESSING WELL WITH RESULTS EXPECTED IN Q3 2020.